AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9541124
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of [14C]-palmitate for 60 min (study A)
Trial: 9541124
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of [14C]-palmitate for 60 min (study A) and 10 min (study B)
Trial: 2667597
Drug: Nicardipine 40
RxNorm normalized name: niCARdipine 40 mg/200 mL-D5% intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 40 mg
Trial: 22114900
Drug: Ropivacaine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 7.5 mg/ml
Trial: 9291287
Drug: Local nasal
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local nasal immunotherapy (LNIT) with extracts in powder, administered pre-seasonally.
Trial: 12444376
Drug: Prophylactic injection
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic injection therapy with 1% aethoxysclerol (group-1)
Trial: 12444376
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment without perendoscopic therapy (group-2)
Trial: 2240672
Drug: Midazolam 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.75 mg.kg-1 po and atropine 0.03 mg.kg-1 po
Trial: 23375025
Drug: Rilonacept 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilonacept 320 mg SC plus indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days
Trial: 23375025
Drug: Indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days
Trial: 23375025
Drug: Rilonacept 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilonacept 320 mg SC plus oral placebo
Trial: 17004672
Drug: Supplemental reading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental reading intervention daily for 50 minutes in small groups from October to April
Trial: 15005325
Drug: Plastic tanks
RxNorm normalized name: plastic IUD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plastic tanks filled with water, saline, and ferric solutions for calibration purposes.
Trial: 9472058
Drug: Iodixanol 320
RxNorm normalized name: IODIXANOL 320mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol 320 mgI/ml
Trial: 30696306
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of indomethacin and nifedipine
Trial: 29420695
Drug: 1 tablet
RxNorm normalized name: Ovral-21 Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 tablet daily
Trial: 29420695
Drug: 1 tablet
RxNorm normalized name: Ovral-21 Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 tablet twice weekly with a postsex dose (time‐driven)
Trial: 29420695
Drug: 1 tablet
RxNorm normalized name: Ovral-21 Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 tablet before and after sex (event‐driven)
Trial: 29420695
Drug: Daily arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily arm
Trial: 17003293
Drug: Basal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal insulin discontinued during exercise
Trial: 9282234
Drug: High-dose inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose inhaled ipratropium bromide (total dose of 144 micrograms)
Trial: 8102213
Drug: Inhaled fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fenoterol 4 mg after placebo
Trial: 8102213
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol 4 mg after placebo
Trial: 8102213
Drug: Inhaled fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fenoterol 4 mg after atenolol
Trial: 15063959
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution misoprostol 400 microg
Trial: 15063959
Drug: Oral tablet
RxNorm normalized name: Oral Tablet
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tablet misoprostol 400 microg
Trial: 20043525
Drug: Rectal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal misoprostol 400 microg
Trial: 7515453
Drug: Combined administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined administration of 100 to 250 micrograms/day of G‐CSF, 400 to 800 mg/day of MCZ, and various antibiotics (Group I)
Trial: 7515453
Drug: MCZ and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCZ and antibiotics
Trial: 22670050
Drug: 2009-2010 seasonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2009-2010 seasonal trivalent inactivated influenza vaccine (TIV)
Trial: 12734690
Drug: Acetazolamide (ACZ)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (ACZ) injection 10 min before the second dose of N-isopropyl-[123I] p-iodoamphetamine (IMP)
Trial: 8564973
Drug: Carboxyamido‐triazole (CAI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboxyamido‐triazole (CAI) administered p.o. daily or every other day
Trial: 8564973
Drug: Carboxyamido‐triazole (CAI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboxyamido‐triazole (CAI) administered p.o. at 175 mg/m2/day (liquid formulation)
Trial: 8564973
Drug: Carboxyamido‐triazole (CAI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboxyamido‐triazole (CAI) administered p.o. at 330 mg/m2 every‐other‐day (liquid formulation)
Trial: 6137227
Drug: Midazolam 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.075 mg kg‐1
Trial: 6137227
Drug: Diazepam 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.15 mg kg‐1
Trial: 17638394
Drug: Dexketoprofen 50mg
RxNorm normalized name: dexketoprofen
DrugBank: Dexketoprofen (DB09214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen 50mg twice daily
Trial: 17638394
Drug: Diclofenac 75mg
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac 75mg twice daily
Trial: 12901810
Drug: Protective plastic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective plastic oral guard
Trial: 6161788
Drug: Xylene 700
RxNorm normalized name: xylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylene 700 mg/m3 + Alcohol 0.8 g/kg
Trial: 30706836
Drug: Indapamide retard
RxNorm normalized name: Indapamide
DrugBank: Indapamide (DB00808)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indapamide retard 1.5 mg and valsartan 160 mg in the morning (Group 3)
Trial: 21881478
Drug: Etravirine 400
RxNorm normalized name: Etravirine
DrugBank: Etravirine (DB06414)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Etravirine 400 mg once daily
Trial: 17445476
Drug: Routine medical
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine medical treatment (oxygen, aminophylline, dexamethasone, and furosemide)
Trial: 16624192
Drug: Misoprostol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (50 microg oral, 4 hourly to a maximum of four doses)
Trial: 16624192
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three agents (Dinoprostone, Foley catheter, Misoprostol)
Trial: 9026379
Drug: Pindolol 30
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol 30 mg, p.o.
Trial: 2068470
Drug: Clindamycin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin plus aztreonam (900 mg clindamycin + 1 g aztreonam)
Trial: 2068470
Drug: Clindamycin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin plus cefotaxime (900 mg clindamycin + 1 g cefotaxime)
Trial: 25090264
Drug: Add-on sitagliptin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Add-on sitagliptin (50 mg/day)
Trial: 22147480
Drug: Ammonia concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ammonia concentration 21 mg/m3
Trial: 22147480
Drug: Ammonia concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ammonia concentration 34 mg/m3
Trial: 22147480
Drug: Ammonia concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ammonia concentration 4 mg/m3
Trial: 19714601
Drug: Physiotherapist‐guided treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapist‐guided treatment
Trial: 9656849
Drug: Experimental agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental agent group
Trial: 17589833
Drug: Paroxetine 40
RxNorm normalized name: PARoxetine 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 40 mg
Trial: 19934804
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (triamcinolone and lidocaine)
Trial: 12779069
Drug: Standard eradicating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard eradicating treatment
Trial: 12779069
Drug: 1-month course
RxNorm normalized name: moth bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-month course of empirical treatment
Trial: 8308713
Drug: 1-mg tablet
RxNorm normalized name: haloperidol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-mg tablet given twice daily
Trial: 8308713
Drug: 1-mg capsule
RxNorm normalized name: haloperidol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-mg capsule given twice daily
Trial: 31573689
Drug: Isoproterenol infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoproterenol infusion (beta-adrenergic agonist)
Trial: 29802627
Drug: 1% Metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% Metformin gel
Trial: 27206266
Drug: Mephedrone 200
RxNorm normalized name: ephedrine
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mephedrone 200 mg
Trial: 17392542
Drug: Cinnamon (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnamon (1 g/day)
Trial: 11863124
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron supplementation (100 mg every 2 weeks or 1 month)
Trial: 10424314
Drug: Acarbose (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (100 mg 3 times daily for 1 year)
Trial: 16466168
Drug: Western medicinal
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicinal treatment (WM) with additional medication of CHM (modified Huxin Recipe)
Trial: 16466168
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medicinal treatment (WM)
Trial: 12645801
Drug: Interferon-alpha-2b at
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha-2b at 5 MU daily
Trial: 18166199
Drug: Hydroxyurea (HU)
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea (HU) at 40 mg/kg/day
Trial: 8558634
Drug: Interleukin-2 and
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interleukin-2 and interferon-alpha 2b (4 x 4.8 x 10(6) IU/m.2 interleukin-2 subcutaneously on days 1 and 22, 2 x 4.8 x 10(6) IU/m.2 on days 2 and 23, and 2 x 2.4 x 10(6) IU/m.2 combined with interferon-alpha 2b subcutaneously at 3 x 10(6) IU/m.2 on days 3, 5, 24 and 26, and 6 x 10(6) IU/m.2 3 times weekly for 6 weeks)
Trial: 22985134
Drug: 4 weeks
RxNorm normalized name: risperiDONE 75 mg/4 weeks intramuscular powder for injection, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 weeks of treatment with one of 5 different dosing combinations (2 or 3 30-min treatments per week or 1, 2, or 3 60-min treatments per week)
Trial: 22985134
Drug: 6 weekly
RxNorm normalized name: tobramycin 28 MG inhalation powder 56 Weekly Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 weekly 60-min massages
Trial: 16429658
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg daily for 6 weeks
Trial: 16429658
Drug: Finasteride 5
RxNorm normalized name: finasteride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 5 mg daily for 6 weeks
Trial: 12630022
Drug: Prostaglandin E1
RxNorm normalized name: Prostaglandin E1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin E1 and steroid administration
Trial: 12630022
Drug: Postoperative management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative management with steroid, prostaglandin E1, and C-tube drainage
Trial: 10226860
Drug: Captopril plus
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril plus diuretics
Trial: 10226860
Drug: Digoxin plus
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin plus diuretics
Trial: 8764421
Drug: Hydroxyzine (Aterax)
RxNorm normalized name: Hydroxizine
DrugBank: Hydroxyzine (DB00557)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxyzine (Aterax) 1‐2 mg/kg
Trial: 1860324
Drug: Standard doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard doses of epinephrine (1 mg iv every 5 mins)
Trial: 6354248
Drug: Diversional occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diversional occupational therapy
Trial: 23975236
Drug: Peginterferon alfa-2b
RxNorm normalized name: Peginterferon alfa-2b
DrugBank: Peginterferon alfa-2b (DB00022)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peginterferon alfa-2b (60 μg/m(2)/wk) plus oral ribavirin (15 mg/kg/day)
Trial: 20937312
Drug: 60 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 μg YIC therapeutic vaccine
Trial: 18582568
Drug: Diclofenac extended
RxNorm normalized name: diclofenac Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac extended release (ER) tablet using the conventional dissolution apparatus (USP II)
Trial: 18582568
Drug: Plasma concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma concentration versus time profiles after the administration of an ER tablet
Trial: 12952230
Drug: EBVD chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EBVD chemotherapy
Trial: 1815019
Drug: Normal oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal oral hygiene practices (Control)
Trial: 27480383
Drug: Nerve growth
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerve growth factor (NGF) injection
Trial: 12115356
Drug: Azoles antifungal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azoles antifungal agents (fluconazole, itraconazole, ketoconazole, miconazole)
Trial: 10195512
Drug: i.a. bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.a. bupivacaine (30 mL of 0.25%) + clonidine (1 microg/kg) i.a.
Trial: 10195512
Drug: i.a. bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.a. bupivacaine (30 mL of 0.25%)
Trial: 10195512
Drug: i.a. bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.a. bupivacaine (30 mL of 0.25%) + subcutaneous clonidine (1 microg/kg)
Trial: 10195512
Drug: i.a. bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.a. bupivacaine (30 mL of 0.25%) + epinephrine (5 microg/mL)
Trial: 2157640
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (intravenous plus oral)
Trial: 2157640
Drug: Cisplatin (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (70 mg/m2)
Trial: 25541155
Drug: Docetaxel treatment
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel treatment
Trial: 31027929
Drug: PHiD-CV10 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHiD-CV10 vaccine
Trial: 31027929
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine (hepatitis A or B vaccine)
Trial: 17692723
Drug: Tretinoin gel
RxNorm normalized name: Tretinoin Gel
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin gel microspheres 0.04%
Trial: 11697427
Drug: Multidisciplinary behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary behavioural treatment
Trial: 9803573
Drug: Self-help programme
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-help programme for climacteric and menopause, consisting of 10 weekly hour-long sessions including body movement exercises, relaxation, and group discussions.
Trial: 2148360
Drug: High-dosage phenobarbital
RxNorm normalized name: hepatitis B surface antigen vaccine
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dosage phenobarbital and cefotaxime
Trial: 28779928
Drug: SilAtro‐5‐90 in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SilAtro‐5‐90 in addition to standard symptomatic treatment
Trial: 21739700
Drug: Electroacupuncture compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture compound anesthesia (Sibai ST 2, Xiaguan ST 7, Hegu LI 4, Zhigou TE 6 on left side; routine local anesthesia on right side)
Trial: 21739700
Drug: Electroacupuncture compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture compound anesthesia
Trial: 12495686
Drug: PMX-F treatment
RxNorm normalized name: F-15599
DrugBank: F-15599 (DB16936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMX-F treatment (N=15)
Trial: 12495686
Drug: Teicoplanin treatment
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin treatment (N=15)
Trial: 12495686
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (N=10)
Trial: 1859070
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 4% lidocaine to the oral mucosa
Trial: 30415298
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 µg once daily with theophylline 100 mg twice daily (Group I)
Trial: 30415298
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 µg once daily (Group II)
Trial: 1662119
Drug: Didemnin B
RxNorm normalized name: Dehydrodidemnin B
DrugBank: Plitidepsin (DB04977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didemnin B at doses ranging from 3.47 to 9.1 mg/m2
Trial: 1662119
Drug: Didemnin B
RxNorm normalized name: Dehydrodidemnin B
DrugBank: Plitidepsin (DB04977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didemnin B at a recommended dose of 6.3 mg/m2
Trial: 1662119
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antiemetics including dexamethasone
Trial: 7073046
Drug: Oxacillin 500
RxNorm normalized name: oxacillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxacillin 500 mg QID x 5 days
Trial: 30830377
Drug: L-aspartic acid
RxNorm normalized name: L-Aspartic Acid
DrugBank: Aspartic acid (DB00128)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-aspartic acid
Trial: 26884590
Drug: Sorafenib +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib + Everolimus (S + E) 800 mg + 5 mg daily
Trial: 21988149
Drug: Fenoprofen Calcium
RxNorm normalized name: Fenoprofen Calcium
DrugBank: Fenoprofen (DB00573)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fenoprofen Calcium (200 mg) in three-layered gum tablet (1800 mg)
Trial: 21988149
Drug: Lyophilized ternary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lyophilized ternary complex containing 100 mg of Fn with PVP K(25)
Trial: 21988149
Drug: Fenoprofen Calcium
RxNorm normalized name: Fenoprofen Calcium
DrugBank: Fenoprofen (DB00573)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fenoprofen Calcium (100 mg) in chewing gum
Trial: 21988149
Drug: Selected gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selected gum tablet
Trial: 15892043
Drug: Capecitabine plus
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine plus docetaxel (1250 mg/m2 twice daily on Days 1-14 plus docetaxel 75 mg/m2 on Day 1)
Trial: 15892043
Drug: Docetaxel alone
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel alone (100 mg/m2 on Day 1)
Trial: 11845111
Drug: Non-hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-hormone replacement therapy (nonHRT) alternatives